When you’re healthy, it’s easy to take each breath for granted. But for the 100,000 people living with idiopathic pulmonary fibrosis (IPF) in the United States — and the 50,000 new cases diagnosed each year — every breath matters. IPF is a disease in which scarring and hardening of lung tissue stops the lungs from working properly. Faced with a complex diagnosis process, limited treatment options, and no known cure, patients’ odds are incredibly long: only half survive beyond two to five years from detection.
There are only a few medical centers in the world equipped with the comprehensive resources to diagnose, treat and study the many forms of pulmonary fibrosis. Michigan Medicine is one of them, thanks to its internationally recognized faculty in the Division of Pulmonary and Critical Care Medicine.
September is Pulmonary Fibrosis Awareness month and the Division of Pulmonary and Critical Care Medicine is stepping up to secure needed funds for their leading IPF fund, Quest for Breath. Formed by the Galvin Family in 2004, Quest for Breath was created to support the advancement of research and identification of new therapies, bolster patient wellness through a support group, and to bring awareness to this devastating disease.
You can join Michigan Medicine in the fight against IPF by making a donation to Quest for Breath. Your commitment will be critical in paving the way for investigators to develop viable new approaches to the treatment of lung fibrosis.
Learn more about IPF and Quest for Breath at Michigan Medicine here.